You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Agammaglobulinemia

Showing 1 - 25 of 45
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Immunodeficiency Diseases (PID), Agammaglobulinemia, Hypogammaglobulinemia Trial in Finland, Sweden (Immune Globulin

Completed
  • Primary Immunodeficiency Diseases (PID)
  • +2 more
  • Immune Globulin Intravenous (Human), 10% TVR (Triple Virally Reduced) Solution
  • Gammagard S/D (Solvent/Detergent)
  • Tampere, Finland
  • +5 more
Aug 22, 2021

Haematological Malignancy, Hypogammaglobulinemia Trial (trimethoprim-sulfamethoxazole (co-trimoxazole), amoxycillin/clavulanic

Not yet recruiting
  • Haematological Malignancy
  • Hypogammaglobulinemia
  • trimethoprim-sulfamethoxazole (co-trimoxazole)
  • +2 more
  • (no location specified)
Jan 4, 2023

COVID-19 Vaccine Responses in PIDD Subjects

Recruiting
  • X-linked Agammaglobulinemia
  • +6 more
    • Saint Petersburg, Florida
    • +2 more
    Apr 7, 2022

    Immunoglobulin DeficiencyTreatable Cause of Fatigue in Multiple

    Recruiting
    • Hypogammaglobulinemia
    • +2 more
    • Laboratory test
    • Bern, BE, Switzerland
      University Hospital of Bern Inselspital
    Sep 26, 2022

    Immune Deficiency Disorders, Severe Combined Immunodeficiency, Chronic Granulomatous Disease Trial in Saint Louis (Transplant

    Recruiting
    • Immune Deficiency Disorders
    • +13 more
    • Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan
    • Saint Louis, Missouri
      Washington University
    Apr 25, 2022

    Hypogammaglobulinemia, Bacterial Infections, B-cell Chronic Lymphocytic Leukemia Trial in Columbus, Pittsburgh (Xembify,

    Recruiting
    • Hypogammaglobulinemia
    • +2 more
    • Columbus, Ohio
    • +1 more
    Jan 16, 2023

    Primary Immunodeficiency, Agammaglobulinemia, Hypogammaglobulinemia Trial in Canada, United States (Kedrion IVIG 10%)

    Completed
    Has Results
    • Primary Immunodeficiency
    • +3 more
    • Kedrion IVIG 10%
    • Little Rock, Arkansas
    • +14 more
    Jan 29, 2021

    Rituximab-Induced Hypogammaglobulinemia in Multiple Sclerosis

    Unknown status
    • Multiple Sclerosis
    • Hypogammaglobulinemia
    • Serum immunoglobulin titer
    • Sari, Iran, Islamic Republic of
      Bu Ali Sina hospital
    Jul 8, 2020

    Immunodeficiency in MS

    Unknown status
    • Multiple Sclerosis
    • +3 more
    • No Interventions
    • Franklin, Tennessee
      Advanced Neurosciences Institute
    Jun 24, 2020

    Chronic Lymphocytic Leukemia, Hypogammaglobulinemia Trial in Worldwide (Panzyga, Placebo)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Hypogammaglobulinemia
    • Panzyga
    • Placebo
    • Saint Petersburg, Florida
    • +52 more
    Aug 10, 2022

    Infection, Immune Deficiency, Hypogammaglobulinemia Trial in Boston (anti-mycoplasma hominis antibodies)

    Completed
    • Infection
    • +4 more
    • anti-mycoplasma hominis antibodies
    • Boston, Massachusetts
      Brigham and Women's Hosptial
    Jan 13, 2020

    Quality of Life and Neuropsychiatric Sequelae in Patients

    Withdrawn
    • ADA-SCID
      • (no location specified)
      Dec 14, 2019

      Common Variable Immunodeficiency and Related Syndromes

      Recruiting
      • CVID
      • XLA
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 25, 2023

        Primary Immunodeficiency Disease Trial (IVIG)

        Not yet recruiting
        • Primary Immunodeficiency Disease
        • IVIG
        • (no location specified)
        Oct 16, 2023

        Hypogammaglobulinemia Trial in Toronto (subcutaneous immunoglobulin)

        Completed
        • Hypogammaglobulinemia
        • subcutaneous immunoglobulin
        • Toronto, Ontario, Canada
          Princess Margaret Hospital
        May 7, 2019

        Primary Immunodeficiency Disease Trial (Boya IVIG)

        Not yet recruiting
        • Primary Immunodeficiency Disease
        • Boya IVIG
        • (no location specified)
        Nov 21, 2023

        Hypogammaglobulinemia, Lung Transplantation Trial in New York (IVIG, Placebo)

        Completed
        Has Results
        • Hypogammaglobulinemia
        • Lung Transplantation
        • New York, New York
          New York Presbyterian Hospital Lung Transplant Program
        Feb 12, 2019

        Chronic Lymphocytic Leukemia, Fatigue, Fever Trial in Houston (Lenalidomide, Ofatumumab)

        Completed
        Has Results
        • Chronic Lymphocytic Leukemia
        • +9 more
        • Houston, Texas
          M D Anderson Cancer Center
        Apr 16, 2019

        Refractory Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia Trial in

        Completed
        Has Results
        • Refractory Chronic Lymphocytic Leukemia
        • +4 more
        • Portland, Oregon
          OHSU Knight Cancer Institute
        Mar 15, 2021

        Primary Immunodeficiency Disease Trial in Hungary, Italy, Slovakia (Kedrion IVIG 10%)

        Recruiting
        • Primary Immunodeficiency Disease
        • Kedrion IVIG 10%
        • Budapest, Hungary
        • +8 more
        Jun 21, 2021

        Primary Immune Deficiency Disorders, Common Variable Immunodeficiency, X-linked Agammaglobulinaemia Trial in United States

        Completed
        Has Results
        • Primary Immune Deficiency Disorders
        • +3 more
        • Subgam
        • Chandler, Arizona
        • +15 more
        Aug 14, 2018

        Gastrointestinal Inflammation Associated With CVID, CVID Enteropathy Trial run by the NIAID (Stelara (ustekinumab))

        Completed
        Has Results
        • Gastrointestinal Inflammation Associated With CVID
        • CVID Enteropathy
        • Stelara (ustekinumab)
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Aug 10, 2020

        Primary Immunodeficiency Disease Trial in United States (Kedrion IVIG 10%)

        Completed
        Has Results
        • Primary Immunodeficiency Disease
        • Kedrion IVIG 10%
        • North Palm Beach, Florida
        • +10 more
        Jan 26, 2022

        Hypogammaglobulinemia, Congenital Heart Disease Trial in Birmingham (IVIG, Placebo)

        Completed
        Has Results
        • Hypogammaglobulinemia
        • Congenital Heart Disease
        • Birmingham, Alabama
          Children's of Alabama
        Mar 1, 2017

        Investigation of Immune Disorders and Deficiencies

        Unknown status
        • Primary Immune Deficiencies
        • +4 more
          • Fairfax, Virginia
            O&O Alpan LLC
          Apr 3, 2017